Ferrari, considered one of the founders of nanomedicine and transport oncophysics (the physics of mass transport within a cancer lesion), says researchers and clinicians need to understand the limitations of transport mechanisms to identify
effective immunotherapy treatments for patients.
Not exact matches
Dan Chen, head of Roche / Genentech's cancer
immunotherapy unit, told Fortune the data were particularly promising since they could lead to Tecentriq becoming a first response
treatment and give additional credence to the company's argument that
immunotherapies are more
effective the earlier they're given to patients.
He argued that an industry - wide collaborative effort would hasten more targeted, personalized, and
effective cancer
treatments at a time when innovative new medications like
immunotherapies are taking flight.
It's clear this is not going to cure every patient, but
treatments that include
immunotherapy are more
effective than other options.
While clinical trials of such
immunotherapies in other cancers have shown them to be highly
effective in a subgroup of patients, the new study stands out because nearly all patients benefited from the
treatment.
«
Immunotherapy drug
effective for metastatic triple negative breast cancer: Pembrolizumab shown to shrink tumors — regardless of whether patient had prior
treatment.»
Medical researchers are working hard to develop
effective vaccines and other
immunotherapy treatments for pancreatic cancer.
Professor David Wraith, who led the research, said: «Insight into the molecular basis of antigen - specific
immunotherapy opens up exciting new opportunities to enhance the selectivity of the approach while providing valuable markers with which to measure
effective treatment.
These subtypes known as memory T cells may explain why some
immunotherapies are more
effective than others and potentially lead to researchers designing more
effective studies using combination checkpoint blockade
treatments, according to experts at The University of Texas MD Anderson Cancer Center.
This page features information on multiple myeloma and
immunotherapy clinical trials for multiple myeloma patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to people with multiple myeloma.
Immunotherapy has taken hold as an
effective treatment for a variety of advanced cancers, but so far, colorectal cancer has stubbornly resisted.
CAR T - cell therapy targeting B - cell maturation protein may be a new
effective type of
immunotherapy treatment for patients with multiple myeloma.
This page features information on leukemia and
immunotherapy clinical trials for leukemia patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based
treatments to both children and adults with leukemia.
This page features information on liver cancer and
immunotherapy clinical trials for liver cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to liver cancer patients.
New research into CAR - T cell therapy has revealed crucial mechanisms that could help the
immunotherapy technique, which is currently only
effective against blood cancers, be adapted for the
treatment of brain tumors and other forms of solid cancers.
This page features information on head and neck cancer and
immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to head and neck cancer patients.
This page features information on colorectal cancer and
immunotherapy clinical trials for colorectal cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to people with this kind of cancer.
This page features information on cervical cancer and
immunotherapy clinical trials for cervical cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to people with cervical cancer.
This page features information on melanoma and
immunotherapy for melanoma patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to people with melanoma.
This page features information on pancreatic cancer and
immunotherapy clinical trials for pancreatic cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to pancreatic cancer patients.
Immunotherapy has been an
effective treatment for patients with certain types of cancer that have been resistant to chemotherapy and radiation
treatment (e.g., melanoma)
But while there are numerous
immunotherapies approved, many patients and their caregivers are still largely unaware of cancer
immunotherapy's potential to offer
effective treatment options.
«CRI is devoted to funding the research that will make cancer
immunotherapy an
effective treatment option for every patient and in every type of cancer.»
This page features information on breast cancer and
immunotherapy clinical trials for breast cancer patients, and highlights the Cancer Research Institute's role in working to bring
effective immune - based cancer
treatments to people with breast cancer.
Immunotherapy has proven
effective for melanoma, the type of cancer for which Carter received
treatment.